The innovative Swiss pharmaceutical company Kontinental Hockey - - PowerPoint PPT Presentation

the innovative swiss pharmaceutical company kontinental
SMART_READER_LITE
LIVE PREVIEW

The innovative Swiss pharmaceutical company Kontinental Hockey - - PowerPoint PPT Presentation

The innovative Swiss pharmaceutical company Kontinental Hockey League Sports Medicine Seminar KHL Leukerbad, 7th May 2010 The innovative Swis Swiss pharmaceutical company Mepha today Mepha stands for Me dicine and Pha rmacy More than 6


slide-1
SLIDE 1

The innovative Swiss pharmaceutical company

slide-2
SLIDE 2

The innovative Swis Swiss pharmaceutical company

Kontinental Hockey League

Sports Medicine Seminar KHL

Leukerbad, 7th May 2010

slide-3
SLIDE 3

The innovative Swis Swiss pharmaceutical company

Mepha today

■ Mepha stands for Medicine and Pharmacy ■ More than 6 decades of vast experience in R&D, production

and sales

■ Headquarters and worldwide centre for high-tech

manufacturing in Aesch near Basle, Switzerland

■ More than 100 products launched in over 50 countries ■ More than CHF 400 million annual sales.

slide-4
SLIDE 4

The innovative Swis Swiss pharmaceutical company

Mepha´s mission

■ We develop and produce attractive medical products and

services in Switzerland to enable doctors and pharmacists to treat their patients with higher effectiveness and cost awareness.

slide-5
SLIDE 5

The innovative Swis Swiss pharmaceutical company

Ecuador El Salvador Guatemala Nicaragua Panama Colombia Costa Rica Haiti Honduras Peru Trinidad & Tobago

Mepha’s markets worldwide

Mepha’s products are sold in over 50 countries worldwide

Switzerland Europe Estonia Latvia Lithuania Poland Portugal Czechia Finland Malta Slovenia Ukraine USA America Africa Cameroon Ivory Coast Mali Senegal Algeria Benin Senegal Algeria Burkina Faso Chad Congo Brazzaville Egypt Equatorial Guinea Gabon Ghana Kenya Libya Mauritius Niger Nigeria Sudan Tanzania Togo Uganda Asia Armenia Azerbaijan Georgia Hong Kong Japan Kazakhstan Malaysia Singapore Thailand Turkmenistan Uzbekistan Near & Middle East Kingdom of Saudi Arabia Kuwait United Arab Emirates Bahrain Jordan Lebanon Oman Qatar

slide-6
SLIDE 6

The innovative Swis Swiss pharmaceutical company

Mepha group sales (million CHF)

Steady growth for more than a decade

50 100 150 200 250 300 350 400 450 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009

slide-7
SLIDE 7

The innovative Swis Swiss pharmaceutical company

Mepha’s product portfolio

■ With over 100 pharmaceuticals in its portfolio, Mepha offers

a wide variety of products to meet the needs of patients and its broad customer base of doctors, pharmacists and distributors.

Olfen Artequin Simepar Mesporin Gasec Neurorubine Tamsulosina-Mepha Mephaquin Bactiflox Mepharis

slide-8
SLIDE 8

The innovative Swis Swiss pharmaceutical company

Our core competencies

■ Top Swiss quality ■ Galenic innovation ■ High-tech manufacturing technologies ■ Expertise in malaria research